Latest filing published 19 Feb 2026 for Neumora Therapeutics, Inc., €4,320.
Filing timeline
BuySaleInsider track record
Michael Lee Milligan: trading record in brief
All filings by Michael Lee Milligan on record concern Neumora Therapeutics, Inc. Between 14 February 2024 and 17 February 2026, the trades on record add up to 3 filings.
The open-market record consists of 2 sales worth €7,516, with no purchase. Outside the open market, there are 1 share grant. 2026 to date brings no purchases and 1 sale.
The record was last updated on 19 February 2026 with an open-market sale (€4,320) in Neumora Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Lee Milligan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,436 shares@ US$3.56557.5% of flowCommon StockSEC:0001610717-26-000051:0
- 1,978 shares@ US$1.693942.5% of flowCommon StockSEC:0001610717-25-000030:0
- 20,625 shares0Common StockSEC:0001610717-24-000064:0
3 of 3 declarations
